The ‘Ertapenem Injection Market study‘ 2020 offers an in-depth analysis pertaining to potential drivers fueling this industry. The study also elucidates valuable insights about profitability position, ...

HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)-- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr.

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today the availability in the United States of Ertapenem for Injection in a 1 gram vial presentation. The new product is the generic ...

Dr Reddy's Laboratories Ltd, on Wednesday, announced the launch of Ertapenem for Injection, 1 g/vial, a therapeutic equivalent generic version of Invanz approved by the US Food and Drug Administration ...

Shares of Aurobindo Pharma added 2 percent in the opening trade on Tuesday as company received USFDA approval for Ertapenem injection. The company has received final approval from the USFDA (US Food & ...

Aurobindo Pharma Limited today said it received final approval from the US Foodand Drug Administration (USFDA) to manufacture and market Ertapenem Injection 1 g/vial. Aurobindo's Ertapenem injection ...

HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr.

Dr Reddy's Laboratories Ltd on Wednesday announced the launch of Ertapenem for Injection, 1 g/vial, a therapeutic equivalent generic version of Invanz approved by the US Food and Drug Administration. ...